Investors
Financials
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 15, 2026 – Q1 2026 Sales
April 22, 2026 – 2025 Annual Results
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
Financial Calendar
January 15, 2026 – Fourth Quarter 2025 Sales
April 9, 2026 – 2025 Annual Results
April 16, 2026 – Q1 2026 Sales
June 4, 2026 – 2026 Annual General Meeting
July 21, 2026 – Q2 2026 Sales
October 8, 2026 – 2026 Half-Year Results
October 20, 2026 – Q3 2026 Sales
Fourth Quarter And Full Year Sales ended December 31, 2017
Mauna Kea Technologies Renews its Equity Financing Facility to Support its Development
Third Quarter Sales Results 2017
Mauna Kea Technologies Renews its Equity Financing Facility to Support its Development
Sales for the half-year ended June 30, 2017
Sales for the first quarter ended March 31, 2017
2016 Annual Financial Report
Financial results for the full year ended December 31, 2016
Mauna Kea Technologies Secures a €7.0 million Debt Financing
Sales for the fourth quarter and full year ended December 31, 2016
Sales for the third quarter ended September 30, 2016
Financial results for the first half of the current fiscal year, ended June 30, 2016
No results found.
News
Mauna Kea Technologies Reports Strong Q4 2025 Sales Driven by Accelerated Growth in the U.S.
Mauna Kea Technologies and TaeWoong Medical USA Announce Exclusive Partnership to Accelerate Commercial Expansion in the U.S. in Pancreatic Cyst Management
Mauna Kea Technologies Receives NMPA Regulatory Approval in China for its Next-Generation Cellvizio® Platform
No results found.